Terms: = Leukemia AND MEN1, ENSG00000133895, 4221 AND Prognosis
5 results:
1. Multifunctional liposomal nanostructure-mediated siRNA/bortezomib co-delivery for SHARP1 knockdown in MLL-AF6 acute myeloid leukemia.
Mohammed SA; Ju Y
Biomater Adv; 2022 Mar; 134():112663. PubMed ID: 35577689
[TBL] [Abstract] [Full Text] [Related]
2. Menin is necessary for long term maintenance of meningioma-1 driven leukemia.
Libbrecht C; Xie HM; Kingsley MC; Haladyna JN; Riedel SS; Alikarami F; Lenard A; McGeehan GM; Ernst P; Bernt KM
Leukemia; 2021 May; 35(5):1405-1417. PubMed ID: 33542482
[TBL] [Abstract] [Full Text] [Related]
3. A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid leukemia.
Tzelepis K; Koike-Yusa H; De Braekeleer E; Li Y; Metzakopian E; Dovey OM; Mupo A; Grinkevich V; Li M; Mazan M; Gozdecka M; Ohnishi S; Cooper J; Patel M; McKerrell T; Chen B; Domingues AF; Gallipoli P; Teichmann S; Ponstingl H; McDermott U; Saez-Rodriguez J; Huntly BJP; Iorio F; Pina C; Vassiliou GS; Yusa K
Cell Rep; 2016 Oct; 17(4):1193-1205. PubMed ID: 27760321
[TBL] [Abstract] [Full Text] [Related]
4. Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription.
Xu B; Li SH; Zheng R; Gao SB; Ding LH; Yin ZY; Lin X; Feng ZJ; Zhang S; Wang XM; Jin GH
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17480-5. PubMed ID: 24101467
[TBL] [Abstract] [Full Text] [Related]
5. Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.
Grembecka J; He S; Shi A; Purohit T; Muntean AG; Sorenson RJ; Showalter HD; Murai MJ; Belcher AM; Hartley T; Hess JL; Cierpicki T
Nat Chem Biol; 2012 Jan; 8(3):277-84. PubMed ID: 22286128
[TBL] [Abstract] [Full Text] [Related]
